ArticleCancer medicine2023

Analysis of clinicopathological characteristics and prognostic factors of early-stage human epidermal growth factor receptor 2 (HER2)-low breast cancer: Compared with HER2-0 breast cancer.

Qian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.